RAD51 and cancer: HSF4‐mediated RAD51 expression has not been evaluated in cancer, where elevated RAD51 expression is linked to poor prognosis [131, 132], but has been demonstrated to counteract the accumulation of cataract‐promoting DNA damage in the lens [129].